Loading...
48 Middle East and Africa Oncology Drugs Reports
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Takeda Pharmaceuticals, Bristol-Myers Squibb, Lupin, Accord Healthcare, Otsuka
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Pfizer
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen, AstraZeneca, Roche, Eli Lilly and Company, GlaxoSmithKline
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Merck, Bristol-Myers Squibb, Roche, Bio-Rad Laboratories, Azurity Pharmaceuticals
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, South Korea, Australia, South Africa, Brazil, Argentina
Major Players: Abbvie, Eli Lilly and Company, Merck, Boehringer Ingelheim, Astellas Pharma
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, India, Japan, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bausch Health, Roche, Sanofi, Sun Pharmaceuticals Industries, Viatris
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bristol-Myers Squibb, Merck, Biogen, Amneal Pharmaceuticals, Seagen
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Merck, Aphios, Helsinn Group, Bristol-Myers Squibb, Pfizer
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bayer, Roche, Eisai, Novartis, Merck
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen, Bayer, Bristol-Myers Squibb, Roche, AstraZeneca
Region Covered: Middle East and Africa
Study Period: 2020 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen, Bristol-Myers Squibb, Roche, Novartis, Sanofi
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen, Novartis, Merck, Johnson & Johnson, Roche
Region Covered: Middle East and Africa
Study Period: 2022 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bristol-Myers Squibb, Merck, Novartis, Amgen, Pfizer, Sanofi
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen, Bayer, Pfizer, Novartis, Johnson & Johnson
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, South Korea, Australia, South Africa, Brazil, Argentina
Major Players: Pfizer, Bristol-Myers Squibb, Novartis, Roche, Amgen
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Arbor Pharmaceuticals, Roche, Merck, Sun Pharmaceuticals Industries, Teva Pharmaceutical Industries
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AstraZeneca, Bayer, Roche, Teva Pharmaceutical Industries, Seagen Inc
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Eli Lilly and Company, AstraZeneca, GlaxoSmithKline, Novartis, Pfizer
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Novartis, Eli Lilly and Company
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Spain, Italy, China, India, Japan, South Korea, Australia, South Africa, Brazil, Argentina
Major Players: Roche, Bristol-Myers Squibb, Pfizer, AstraZeneca, Novartis
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bristol-Myers Squibb, Bayer, Roche, Eisai, Merck
Region Covered: Middle East and Africa
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bausch Health, Celgene, Helsinn Healthcare, Kyowa Kirin, Merck
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Baxter, GlaxoSmithKline, Pfizer, Johnson & Johnson, Novartis
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bayer, Eisai, Exelixis, Sanofi, Curium Pharma
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bristol-Myers Squibb, Eli Lilly and Company, Merck, Novartis, GlaxoSmithKline
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer, Novartis, Ipsen, Boehringer Ingelheim, Eli Lilly and Company
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bristol-Myers Squibb, Genmab, Novartis, Pfizer, Kyowa Kirin
Region Covered: Middle East and Africa
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bristol-Myers Squibb, Merck, Johnson & Johnson, Novartis, Roche
Region Covered: Middle East and Africa
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bristol-Myers Squibb, Pfizer, Teva Pharmaceutical Industries, Takeda Pharmaceuticals, Novartis
Region Covered: Middle East and Africa
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer, Novartis, Sanofi, Otsuka, Bristol-Myers Squibb
Filter Reports
By Countries
